Kate Chipperfield

Contact Information
Department of Pathology & Laboratory Medicine
University of British Columbia
Div of Hematopathology, BC Children’s & Women’s Hospital
Rm 2K49, 4480 Oak Street, Vancouver, BC, Canada, V6H 1M9
Tel 1-604-875-2044
kate.chipperfield@cw.bc.ca

Current Positions

  • Division Head, Hematopathology, BCCH Dept of Pathology and Laboratory Medicine

Research Interests

  • Development of massive transfusion guideline and policy for Vancouver Coastal Health. Implemented at VGH and Richmond Hospital. 2007
  • Safety in Transfusion Medicine; Completion of pilot trial of automated patient identification in Transfusion Medicine. 2005-2006
  • Collaborated with CBS/CBR scientists on correlating clinical transfusion outcome with a novel in-vitro method of assessing quality of platelet concentrate. 2007-2008

Publications

  1. Maurer-Spurej E, Larsen R, Labrie A, Heaton A, Chipperfield K. Microparticle content of platelet concentrates is predicted by donor microparticles and is altered by production methods and stress. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2016, vol. 55, no. 1, pp. 35-43, 2016
  2. Ponnampalam A, Growe G, Loftus P, Chipperfield K, Bigham M. Acquired peanut hypersensitivity following platelet transfusion. Transfusion medicine (Oxford, England), 2014, vol. 24, no. 6, pp. 426-427, 2014
  3. Trudeau JD, Waters T, Chipperfield K. Should intraoperative cell-salvaged blood be used in patients with suspected or known malignancy? Canadian journal of anaesthesia = Journal canadien d’anesthesie, 2012, vol. 59, no. 11, pp. 1058-1070, 2012
  4. Heidary B, Bell N, Ngai JT, Simons RK, Chipperfield K, Hameed SM. Temporal trends in the treatment of severe traumatic hemorrhage. American journal of surgery, 2012, vol. 203, no. 5, pp. 568-573, 2012
  5. Maurer-Spurej E, Pittendreigh C, Yakimec J, De Badyn MH, Chipperfield K. Erroneous automated optical platelet counts in 1-hour post-transfusion blood samples. International journal of laboratory hematology, 2010, vol. 32, no. 1 Pt 1, pp. e1-8, 2010
  6. Bruyère H, Sutherland H, Chipperfield K, Hudoba M. Concomitant and successive amplifications of MYC in APL-like leukemia. Cancer genetics and cytogenetics, 2010, vol. 197, no. 1, pp. 75-80, 2010
  7. Maurer-Spurej E, Labrie A, Pittendreigh C, Chipperfield K, Smith C, Heddle N, Liu Y, Yi QL, Barnett M. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Transfusion, 2009, vol. 49, no. 11, pp. 2276-2284, 2009
  8. Maurer-Spurej E, Chipperfield K. Past and future approaches to assess the quality of platelets for transfusion. Transfusion medicine reviews, 2007, vol. 21, no. 4, pp. 295-306, 2007
  9. Saxena A, Dyker KM, Angel S, Moshynska O, Dharampaul S, Cockroft DW. Posttransplant diffuse large B-cell lymphoma of “lymphomatoid granulomatosis” type. Virchows Archiv : an international journal of pathology, 2002, vol. 441, no. 6, pp. 622-628, 2002
  10. Maurer-Spurej E, Dyker K, Gahl WA, Devine DV. A novel immunocytochemical assay for the detection of serotonin in platelets. British journal of haematology, 2002, vol. 116, no. 3, pp. 604-611, 2002

Non-refereed Publications

  1. Frketich J, Pal J, Pi S, Medvedev N, Chipperfield K. An IVIG Utlization Management Program at Vancouver Coastal Health Hospitals. Canadian Society for Transfusion Medicine Meeting 2010. Short oral presentation. 2010
  2. Tan W-S, Roland K, Selin S and Chipperfield K on behalf of BC Transfusion medicine advisory group and the BC transfusion Medicine service medical directors. Introduction of Guidelines for the use of albumin and the effect on albumin prescribing practices in British Columbia. Canadian Society for Transfusion Medicine Meeting 2010. Abstract. 2010
  3. Tan W-S, Roland K, Selin S and Chipperfield K on behalf of BC Transfusion medicine advisory group and the BC transfusion Medicine service medical directors. The first year of Octaplex use in British Columbia: A quality assurance audit. Canadian Society for Transfusion Medicine Meeting 2010. Abstract. 2010
  4. Roland K, Chipperfield K and Al-Riyami A. Octaplex usage one year after implementation at a tertiary care hospital. Canadian Society for Transfusion Medicine Meeting 2010. Abstract. 2010
  5. Chipperfield K, Roland K, and Maurer-Spurej E. The CoDivo RCT: A planned randomized controlled trial of high quality platelet transfusion support versus standard transfusion care in patients with hematologic malignancy and stem cell transplant. Canadian Society for Transfusion Medicine Meeting 2010. Abstract. 2010
  6. Feenstra S, Chipperfield K, Mah H. Implementation of physician’s pre-preinted order sets for blood component and blood product at two hospitals: an example of process change. Canadian Society for Transfusion Medicine Meeting 2010. Abstract. 2010
  7. MacDonald G, Feenstra S, Chipperfield K, and Mah H. Implementing and managing a remote satellite blood supply to support the whistler polyclinic/mobile medical unit in the absence of on-site TM laboratory services. Canadian Society for Transfusion Medicine Meeting 2010. Abstract. 2010
  8. Roland K and Chipperfield K. Impact of buffy coat platelet production method on ABO unmatched platelet transfusions in a tertiary care hospital. Canadian Society for Transfusion Medicine Meeting 2010. Abstract. 2010
  9. Roland K, Chipperfield K. Impact of buffy coat method of platelet shelf life and outdating rates. Canadian Society for Transfusion Medicine Meeting 2009. Abstract.
  10. Roland K, Chipperfield K. Age of blood accepted into inventory within a region participating in blood redistribution. Canadian Society for Transfusion Medicine Meeting 2009. Abstract.
  11. Chipperfield K, Roland K. A dedicated Transfusion Medicine rotation for Clinical Pathology and Hematology Residents: The UBC Experience. Canadian Society for Transfusion Medicine Meeting 2009. Abstract.
  12. Bruyère H, Horsman D, Chipperfield K, Forrest D, De Badyn H, Song K and Humphries RK. Two new cases of translocation involving NUP98 in AML Patients. American Cytogenetics Conference, April 2008.
  13. Maurer-Spurej E, Labrie A, Brown K, Shustik J, Lam D, Barnett M, Smith C, Chipperfield K. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. American Association of Blood Bank Meeting 2008. Abstract.
  14. Roland K, Barr K, Wolley S, Lampa M, Waters T, Chipperfield K. Effect of Timeliness of Referral to a Blood Utilization Program Before Elective Revision Hip Arthroplasty. Canadian Society for Transfusion Medicine Meeting, 2007. Abstract.
  15. Maurer-Spurej E, Dyker KM, Devine DV. New Immuno-Fluorescence Method for the Detection of Serotonin in Patients with Undefined Platelet-Related Bleeding. American Society of Hematology Meeting, 2000. Abstract.

Books

(A) AUTHORED

1.Berry B, Chipperfield K, Morrison D and Petraszko T, for the Provincial Blood Coordinating Office and Transfusion Medicine Advisory Group of British Columbia. Provincial Transfusion Medicine Medical Policy Manual. First Edition. Provincial Blood Coordinating Office, Aug 2007.

(B) EDITED

1.Wadsworth L, Chipperfield K, Herd S, Villar K, Editors. Provincial Transfusion Medicine Medical Policy Manual, First Edition. Provincial Blood Coordinating Office, Aug 2007.

(C) CHAPTERS

1.Dyker K. Topics in Adult Hematology. The British Columbia IVIG Utilization Handbook. British Columbia Provincial Blood Coordinating Office, Feb 2002.

Education

  • M.D., University of Saskatchewan, 1996